Xia W, Veeragandham P, Cao Y, Xu Y, Rhyne T, Qian J, et al. Obesity-dependent increase in RalA activity disrupts mitochondrial dynamics in white adipocytes. Res Sq. 2023;: pubmed publisher

Li J, Zhou J, Mu X, Shen S, Xu X, Luo Y, et al. Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma. MedComm (2020). 2022;3:e125 pubmed publisher

Pan W, Nagpal K, Suárez Fueyo A, Ferretti A, Yoshida N, Tsokos M, et al. The Regulatory Subunit PPP2R2A of PP2A Enhances Th1 and Th17 Differentiation through Activation of the GEF-H1/RhoA/ROCK Signaling Pathway. J Immunol. 2021;206:1719-1728 pubmed publisher

Pan W, Sharabi A, Ferretti A, Zhang Y, Burbano C, Yoshida N, et al. PPP2R2D suppresses IL-2 production and Treg function. JCI Insight. 2020;5: pubmed publisher

Qiu Z, Fa P, Liu T, Prasad C, Ma S, Hong Z, et al. A genome-wide pooled shRNA screen identifies PPP2R2A as a predictive biomarker for the response to ATR and CHK1 inhibitors. Cancer Res. 2020;: pubmed publisher

Cockman M, Lippl K, Tian Y, Pegg H, Figg W, Abboud M, et al. Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates. elife. 2019;8: pubmed publisher

Yin Q, Han T, Fang B, Zhang G, Zhang C, Roberts E, et al. K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling. Nat Commun. 2019;10:1870 pubmed publisher

Chen W, Possemato R, Campbell K, Plattner C, Pallas D, Hahn W. Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell. 2004;5:127-36 pubmed